Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US OTC Switch Drought Ends: FDA Approves GSK Arthritis Gel, Alcon Allergy Eye Drops

Feb 17 2020

• By Malcolm Spicer

FDA Approved

Related Content

OTC Primatene Mist Returns: Market Future Bright After Cloudy NDA History

Nov 10 2018

GSK Unveils Two-Year Plan For Consumer Split

Feb 06 2020

Approval Briefs: Zohydro ER, Vyvanse For Binge Eating, Another Imbruvica Claim, Alcon Gains New Allergy Eye Drop

Feb 03 2015

All 'Bye' Itself: Alcon Spins Out From Novartis In $25Bn Stock Listing

Apr 09 2019

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance

Jul 17 2018

Newly Approved OTC Eye Drop Could Boost Valeant Turnaround Outlook

Dec 29 2017

FDA Has Model Drug Facts Labels For OTC Naloxone, Wants Switch Proposals

Jan 18 2019

FDA Plans To Publish 'Novel' OTC Switch NPRM In May 2020

Nov 22 2019

Sanofi Licenses OTC Tamiflu From Roche To Attempt First US Flu Treatment Switch

Jul 23 2019

Related Companies

GSK plc

Alcon Inc.

Novartis AG

Pfizer Inc.

Bausch Health Companies Inc.

Sanofi

Roche Holding AG

Genentech, Inc.

Amphastar Pharmaceuticals, Inc.

Additional Topics

United Kingdom Europe International Switzerland United States OTC Drugs Prescription To OTC Switch FDA Advertising, Marketing & Sales Business Strategies Commercial Companies Drug Approval Standards Ingredients Manufacturing Policy Regulation Consumer Inflammation Immune Disorders

More from Rx-to-OTC Switch

More from Health

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window